Fink, Nadia Rahman
Chawes, Bo http://orcid.org/0000-0001-6846-6243
Bønnelykke, Klaus http://orcid.org/0000-0003-2003-1018
Thorsen, Jonathan http://orcid.org/0000-0003-0200-0461
Stokholm, Jakob http://orcid.org/0000-0003-4989-9769
Rasmussen, Morten Arendt
Brix, Susanne http://orcid.org/0000-0001-8951-6705
Bisgaard, Hans http://orcid.org/0000-0003-4131-7592
Funding for this research was provided by:
Lundbeckfonden (Grant no R16-A1694, Grant no R16-A1694, Grant no R16-A1694, Grant no R16-A1694, Grant no R16-A1694, Grant no R16-A1694)
Sundhedsstyrelsen (Grant no 903516, Grant no 903516, Grant no 903516, Grant no 903516, Grant no 903516, Grant no 903516)
Strategiske Forskningsråd (Grant no 0603-00280B, Grant no 0603-00280B, Grant no 0603-00280B, Grant no 0603-00280B, Grant no 0603-00280B, Grant no 0603-00280B)
All funding received by COPSAC is listed on www.copsac.com.
Article History
Received: 16 November 2018
Accepted: 25 January 2019
First Online: 28 February 2019
Competing Interests
: All authors declare no potential, perceived, or real conflict of interest regarding the content of this manuscript. All authors further declare no competing, financial or non-financial conflicts of interest as outlined in the editorial policies of this journal. The funding agencies did not have any role in design and conduct of the study; collection, management, and interpretation of the data; or preparation, review, or approval of the manuscript. No pharmaceutical company was involved in the study.